Pharmaceutical companies in the United States by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Merck & Co leads the 19 pharmaceutical companies in the United States ranked by P/E ratio, at 134, ahead of Ligand Pharmaceuticals (115) and TG Therapeutics (96.8). Figures as of 19 Nov 2026, 23:07 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
Merck & Co134
Median
39.3
Combined market value
$3.74T
Countries
1
Not ranked
25no P/E ratio on file

Market values as of .

United States
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in the United States by P/E ratio
#CompanyP/E ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Merck & CoMRK · Health Care134$327.4B$132.81 3.61% down 45% up United States
2Ligand PharmaceuticalsLGND · Health Care115$5.7B$286.94 3.94% down 50% up United States
3TG TherapeuticsTGTX · Health Care96.8$9.8B$64.88 1.88% down 117% up United States
4Amneal PharmaceuticalsAMRX · Health Care53.5$7.5B$21.39 2.24% down 90% up United States
5Corcept TherapeuticsCORT · Health Care48.9$7.1B$64.98 4.15% down 10% down United States
6AbbVieABBV · Health Care48.7$501.2B$283.54 0.86% down 25% up United States
7Royalty PharmaRPRX · Health Care44.3$38.9B$67.72 1.38% down 79% up United States
8Eli LillyLLY · Health Care43.9$1.20T$1,351.12 2.29% down 33% up United States
9Johnson & JohnsonJNJ · Health Care40.5$643.1B$267.14 2.04% down 34% up United States
10PfizerPFE · Health Care39.3$157B$27.54 1.85% down 15% up United States
11Abbott LaboratoriesABT · Health Care38.8$179.9B$103.87 0.58% down 16% down United States
12Vertex PharmaceuticalsVRTX · Health Care33.5$132B$520.66 2.94% down 27% up United States
13Protagonist TherapeuticsPTGX · Health Care26.2$8.1B$124.02 2.47% down 51% up United States
14United TherapeuticsUTHR · Health Care21.1$23.8B$559.10 3.16% down 22% up United States
15Regeneron PharmaceuticalsREGN · Health Care20.4$95.5B$923.34 2.35% down 28% up United States
16ZoetisZTS · Health Care13.7$32.8B$80.79 5.59% down 26% down United States
17Bristol-Myers SquibbBMY · Health Care12.9$119.3B$58.34 2.05% down 30% up United States
18Alnylam PharmaceuticalsALNY · Health Care7.5$19.8B$147.82 1.06% down 66% down United States
19Edgewise TherapeuticsEWTX · Health Care4.9$4.5B$41.17 0.48% down 86% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 25 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies in the United States rank first by P/E ratio?

Merck & Co (134), Ligand Pharmaceuticals (115) and TG Therapeutics (96.8) are the top three of the 19 pharmaceutical companies in the United States ranked by P/E ratio as of 19 Nov 2026, 23:07 UTC.

How many pharmaceutical companies in the United States are in this ranking?

19 are ranked by P/E ratio. 25 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies in the United States worth together?

The 19 pharmaceutical companies in the United States ranked by P/E ratio have a combined market value of $3.74T as of 19 Nov 2026, 23:07 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.